Regression of High-Risk Plaque with Lifestyle Changes

Diet and lifestyle intervention in addition to optimal medical therapy can slow down plaque building and even reduce plaque volume compared against optimal medical treatment (OTM) alone.

Regresión de placas de alto riesgo con cambios del estilo vida

Diet and lifestyle intervention are amongst the most important strategies to manage coronary artery disease. However, its direct impact on atherosclerosis remains unclear. 

Atherosclerosis plaque building is associated with the risk of rupture with cardiovascular consequences regardless stenosis degree. 

The present study recently published in J Am Coll Cardiol Img included 92 patients with non-obstructive coronary lesions by CT scan. 

Patients were randomized 1:1 to an intervention group (systematic followup with nutritionist and lifestyle changes + OTM) vs. A control group (OTM alone). 


Read also: ACC 2019 | The New ACC/AHA Guidelines on Primary Prevention Focus on Life Style, Diet and Socioeconomic Factors.


In all patients, CT was repeated after 66.9 ± 13.7 weeks. Primary end point was atheroma volume change and plaque composition. 

Coronary plaque components were classified based on Hounsfield units into dense calcium (>351 units), fibrous plaque (151 to 350 units) and fibrofatty plaque combined with necrotic core (-30 to 150 units).

Atheroma volume increased in the control branch (changed from 1.1 ± 3.4%; p=0.033) while remaining stable in the intervention group (change from 1% ± 4.2%. p=0.127).


Read also: The Crucial Significance of Lifestyle Changes.


A significant reduction in soft plaque was seen in both branches, though it was higher in the intervention group, where it reached mean 51.3 mm3.

Conclusion

Diet and lifestyle intervention together with OMT can slow down atherosclerosis progression and reduce non-calcified plaque volume compared against OMT alone. 

Original Title: High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonbstructive Coronary Disease. A Randomized Study.

Reference: Jan Henzel et al. J Am Coll Cardiol Img 2020, article in press. https://doi.org/10.1016/j.jcmg.2020.10.019.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...